QQQ   269.09 (-0.45%)
AAPL   445.94 (-1.10%)
MSFT   206.55 (-0.82%)
FB   264.92 (+0.73%)
GOOGL   1,498.05 (+0.08%)
AMZN   3,146.88 (-0.04%)
NVDA   441.36 (-1.17%)
CGC   17.54 (-2.18%)
BABA   252.23 (+1.65%)
TSLA   1,405.29 (-0.94%)
GE   6.87 (+3.00%)
MU   48.71 (-0.90%)
AMD   79.64 (-3.16%)
T   30.49 (+0.96%)
F   7.29 (+2.82%)
ACB   10.07 (-1.47%)
GILD   68.67 (+0.23%)
NFLX   477.77 (-1.16%)
DIS   131.75 (+2.30%)
BAC   27.33 (+2.90%)
BA   185.59 (+3.44%)
QQQ   269.09 (-0.45%)
AAPL   445.94 (-1.10%)
MSFT   206.55 (-0.82%)
FB   264.92 (+0.73%)
GOOGL   1,498.05 (+0.08%)
AMZN   3,146.88 (-0.04%)
NVDA   441.36 (-1.17%)
CGC   17.54 (-2.18%)
BABA   252.23 (+1.65%)
TSLA   1,405.29 (-0.94%)
GE   6.87 (+3.00%)
MU   48.71 (-0.90%)
AMD   79.64 (-3.16%)
T   30.49 (+0.96%)
F   7.29 (+2.82%)
ACB   10.07 (-1.47%)
GILD   68.67 (+0.23%)
NFLX   477.77 (-1.16%)
DIS   131.75 (+2.30%)
BAC   27.33 (+2.90%)
BA   185.59 (+3.44%)
QQQ   269.09 (-0.45%)
AAPL   445.94 (-1.10%)
MSFT   206.55 (-0.82%)
FB   264.92 (+0.73%)
GOOGL   1,498.05 (+0.08%)
AMZN   3,146.88 (-0.04%)
NVDA   441.36 (-1.17%)
CGC   17.54 (-2.18%)
BABA   252.23 (+1.65%)
TSLA   1,405.29 (-0.94%)
GE   6.87 (+3.00%)
MU   48.71 (-0.90%)
AMD   79.64 (-3.16%)
T   30.49 (+0.96%)
F   7.29 (+2.82%)
ACB   10.07 (-1.47%)
GILD   68.67 (+0.23%)
NFLX   477.77 (-1.16%)
DIS   131.75 (+2.30%)
BAC   27.33 (+2.90%)
BA   185.59 (+3.44%)
QQQ   269.09 (-0.45%)
AAPL   445.94 (-1.10%)
MSFT   206.55 (-0.82%)
FB   264.92 (+0.73%)
GOOGL   1,498.05 (+0.08%)
AMZN   3,146.88 (-0.04%)
NVDA   441.36 (-1.17%)
CGC   17.54 (-2.18%)
BABA   252.23 (+1.65%)
TSLA   1,405.29 (-0.94%)
GE   6.87 (+3.00%)
MU   48.71 (-0.90%)
AMD   79.64 (-3.16%)
T   30.49 (+0.96%)
F   7.29 (+2.82%)
ACB   10.07 (-1.47%)
GILD   68.67 (+0.23%)
NFLX   477.77 (-1.16%)
DIS   131.75 (+2.30%)
BAC   27.33 (+2.90%)
BA   185.59 (+3.44%)
Log in

NYSE:USNAUSANA Health Sciences Stock Price, Forecast & News

$83.04
+1.98 (+2.44 %)
(As of 08/11/2020 12:18 PM ET)
Add
Compare
Today's Range
$81.75
Now: $83.04
$83.11
50-Day Range
$68.64
MA: $80.77
$91.20
52-Week Range
$43.01
Now: $83.04
$92.26
Volume1,925 shs
Average Volume148,127 shs
Market Capitalization$1.75 billion
P/E Ratio16.44
Dividend YieldN/A
Beta0.94
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products primarily to reduce the risk of chronic degenerative disease. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include low-glycemic meal replacement shakes, snack bars, and other related products, which provide macro-nutrition. It also provides Sensé—beautiful science products, such as personal care products that support healthy skin and hair through topical nourishment, moisturization, and protection; Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products directly in the Asia Pacific, the Americas, and Europe. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
Read More
USANA Health Sciences logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.3Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 2.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.47 out of 5 stars


Industry, Sector and Symbol

Industry Medicinals & botanicals
Sub-IndustryPersonal Products
SectorMedical
CUSIP90328M10
Phone801-954-7100

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.06 billion
Cash Flow$5.74 per share
Book Value$16.25 per share

Profitability

Net Income$100.53 million

Miscellaneous

Employees1,909
Market Cap$1.75 billion
Next Earnings Date10/27/2020 (Estimated)
OptionableOptionable
$83.04
+1.98 (+2.44 %)
(As of 08/11/2020 12:18 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive USNA News and Ratings via Email

Sign-up to receive the latest news and ratings for USNA and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











USANA Health Sciences (NYSE:USNA) Frequently Asked Questions

How has USANA Health Sciences' stock price been impacted by COVID-19?

USANA Health Sciences' stock was trading at $69.88 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, USNA shares have increased by 18.8% and is now trading at $83.04.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of USANA Health Sciences?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for USANA Health Sciences in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for USANA Health Sciences
.

When is USANA Health Sciences' next earnings date?

USANA Health Sciences is scheduled to release its next quarterly earnings announcement on Tuesday, October 27th 2020.
View our earnings forecast for USANA Health Sciences
.

How were USANA Health Sciences' earnings last quarter?

USANA Health Sciences, Inc. (NYSE:USNA) released its quarterly earnings data on Tuesday, July, 21st. The company reported $1.32 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.08 by $0.24. The business had revenue of $258.99 million for the quarter, compared to analyst estimates of $267.80 million. USANA Health Sciences had a net margin of 10.35% and a return on equity of 32.87%. During the same period in the previous year, the firm earned $0.91 EPS.
View USANA Health Sciences' earnings history
.

How will USANA Health Sciences' stock buyback program work?

USANA Health Sciences announced that its Board of Directors has initiated a stock repurchase plan on Wednesday, February 5th 2020, which authorizes the company to buyback $130,000,000.00 in shares, according to EventVestor. This buyback authorization authorizes the company to repurchase up to 9.1% of its stock through open market purchases. Stock buyback plans are usually a sign that the company's board believes its shares are undervalued.

What guidance has USANA Health Sciences issued on next quarter's earnings?

USANA Health Sciences issued an update on its FY 2020 After-Hours earnings guidance on Tuesday, July, 21st. The company provided EPS guidance of 4.70-5.25 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $4.88. The company issued revenue guidance of $1.05-1.1 billion, compared to the consensus revenue estimate of $1.07 billion.

What price target have analysts set for USNA?

2 equities research analysts have issued 12-month target prices for USANA Health Sciences' shares. Their forecasts range from $65.00 to $65.00. On average, they anticipate USANA Health Sciences' stock price to reach $65.00 in the next year. This suggests that the stock has a possible downside of 21.7%.
View analysts' price targets for USANA Health Sciences
.

Has USANA Health Sciences been receiving favorable news coverage?

News stories about USNA stock have trended neutral recently, InfoTrie Sentiment reports. The research group ranks the sentiment of news coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. USANA Health Sciences earned a media sentiment score of 0.2 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the near future.
View the latest news about USANA Health Sciences
.

Are investors shorting USANA Health Sciences?

USANA Health Sciences saw a increase in short interest during the month of February. As of February 15th, there was short interest totaling 1,580,000 shares, an increase of 12.1% from the January 31st total of 1,410,000 shares. Based on an average trading volume of 149,600 shares, the days-to-cover ratio is currently 10.6 days. Currently, 13.3% of the shares of the company are short sold.
View USANA Health Sciences' Short Interest
.

Who are some of USANA Health Sciences' key competitors?

What other stocks do shareholders of USANA Health Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other USANA Health Sciences investors own include IBM (IBM), Gilead Sciences (GILD), AT&T (T), Chesapeake Energy (CHKAQ), Chesapeake Energy (CHKAQ), NVIDIA (NVDA), AbbVie (ABBV), Amgen (AMGN), Abbott Laboratories (ABT) and Allergan (AGN).

Who are USANA Health Sciences' key executives?

USANA Health Sciences' management team includes the following people:
  • Dr. Myron W. Wentz, Founder & Chairman (Age 78)
  • Mr. Kevin G. Guest, CEO & Director (Age 56)
  • Mr. Jim Brown, Pres & COO (Age 50)
  • Mr. G. Douglas Hekking, Chief Financial Officer (Age 49)
  • Mr. Walter Noot, Chief Information Officer (Age 53)

What is USANA Health Sciences' stock symbol?

USANA Health Sciences trades on the New York Stock Exchange (NYSE) under the ticker symbol "USNA."

Who are USANA Health Sciences' major shareholders?

USANA Health Sciences' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Russell Investments Group Ltd. (0.80%), Principal Financial Group Inc. (0.46%), Robeco Institutional Asset Management B.V. (0.34%), WINTON GROUP Ltd (0.25%), Mackay Shields LLC (0.17%) and MERIAN GLOBAL INVESTORS UK Ltd (0.15%). Company insiders that own USANA Health Sciences stock include Brent Neidig, Daniel A Macuga, Feng Peng, Frederic J Winssinger, G Doug Iiekking, Gilbert A Fuller, Global Ltd Gull, Jim Brown, Joshua Foukas, Kevin Guest, Myron W Wentz, Robert A Sinnott, Robert Auciaux, Timothy E Wood and Walter Noot.
View institutional ownership trends for USANA Health Sciences
.

Which institutional investors are selling USANA Health Sciences stock?

USNA stock was sold by a variety of institutional investors in the last quarter, including UBS Group AG, Robeco Institutional Asset Management B.V., First Quadrant L P CA, Principal Financial Group Inc., Mackay Shields LLC, MERIAN GLOBAL INVESTORS UK Ltd, Trexquant Investment LP, and SG Americas Securities LLC. Company insiders that have sold USANA Health Sciences company stock in the last year include Brent Neidig, Daniel A Macuga, Feng Peng, Frederic J Winssinger, G Doug Iiekking, Gilbert A Fuller, Jim Brown, Joshua Foukas, Kevin Guest, Myron W Wentz, Robert Auciaux, Timothy E Wood, and Walter Noot.
View insider buying and selling activity for USANA Health Sciences
.

Which institutional investors are buying USANA Health Sciences stock?

USNA stock was purchased by a variety of institutional investors in the last quarter, including Empowered Funds LLC, Russell Investments Group Ltd., Bessemer Group Inc., Virtu Financial LLC, WINTON GROUP Ltd, New York State Teachers Retirement System, Aigen Investment Management LP, and Campbell & CO Investment Adviser LLC. Company insiders that have bought USANA Health Sciences stock in the last two years include Global Ltd Gull, and Myron W Wentz.
View insider buying and selling activity for USANA Health Sciences
.

How do I buy shares of USANA Health Sciences?

Shares of USNA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is USANA Health Sciences' stock price today?

One share of USNA stock can currently be purchased for approximately $83.04.

How big of a company is USANA Health Sciences?

USANA Health Sciences has a market capitalization of $1.75 billion and generates $1.06 billion in revenue each year. The company earns $100.53 million in net income (profit) each year or $4.41 on an earnings per share basis. USANA Health Sciences employs 1,909 workers across the globe.

What is USANA Health Sciences' official website?

The official website for USANA Health Sciences is www.usana.com.

How can I contact USANA Health Sciences?

USANA Health Sciences' mailing address is 3838 West Parkway Blvd, Salt Lake City UT, 84120. The company can be reached via phone at 801-954-7100 or via email at [email protected]

This page was last updated on 8/11/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.